Bioline Rx logo

Bioline Rx Share Price (NASDAQ: BLRX)

$3.79

0.14

(3.84%)

Last updated on

Check the interactive Bioline Rx Stock chart to analyse performance

Bioline Rx stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.66
    Today's High:$3.79

    Day's Volatility :3.43%

  • 52 Weeks Low:$2.30
    52 Weeks High:$26.80

    52 Weeks Volatility :91.42%

Bioline Rx Stock Returns

PeriodBioline Rx LtdIndex (Russel 2000)
3 Months
-10.73%
0.0%
6 Months
15.82%
0.0%
1 Year
-85.55%
0.0%
3 Years
-93.86%
-4.7%

Bioline Rx Ltd Key Stats

Check Bioline Rx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.65
Open
$3.66
Today's High
$3.79
Today's Low
$3.66
Market Capitalization
$16.1M
Today's Volume
$7.9K
52 Week High
$26.8
52 Week Low
$2.3001
Revenue TTM
$17.3M
EBITDA
$-10.8M
Earnings Per Share (EPS)
$-6.0
Profit Margin
-45.34%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-45.94%

Stock Returns calculator for Bioline Rx Stock including INR - Dollar returns

The Bioline Rx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioline Rx investment value today

Current value as on today

₹20,253

Returns

₹79,747

(-79.75%)

Returns from Bioline Rx Stock

₹85,032 (-85.03%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Bioline Rx Stock

19%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Bioline Rx Stock from India on INDmoney has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Bioline Rx Ltd

  • Name

    Holdings %

  • Citigroup Inc

    0.09%

  • Wells Fargo & Co

    0.07%

  • Morgan Stanley - Brokerage Accounts

    0.05%

  • Rhumbline Advisers

    0.04%

  • JPMorgan Chase & Co

    0.01%

Analyst Recommendation on Bioline Rx Stock

Rating
Trend

Bioline Rx Share Price Target

What analysts predicted

Upside of 586.02%

Target:

$26.00

Current:

$3.79

Bioline Rx share price target is $26.00, a slight Upside of 586.02% compared to current price of $3.79 as per analysts' prediction.

Bioline Rx Stock Insights

  • Price Movement

    In the last 3 months, BLRX stock has moved down by -30.3%
  • BLRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 155.8%
  • BLRX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 206.5%
  • Price to Sales

    ForBLRX every $1 of sales, investors are willing to pay $0.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Bioline Rx Technicals Summary

Sell

Neutral

Buy

Bioline Rx is currently in a neutral trading position according to technical analysis indicators.

Bioline Rx Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Bioline Rx Ltd logo
-5.43%
15.82%
-85.55%
-93.86%
-94.8%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Bioline Rx Ltd

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Organization
Bioline Rx
Employees
28
CEO
Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA
Industry
Health Technology

Key Management of Bioline Rx Ltd

NameTitle
Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA
Chief Executive Officer
Dr. Ella Sorani Ph.D.
Chief Development Officer
Mr. John Lacey
Head of Corporate Communications & Investor Relations
Mr. Raziel Fried
Treasurer & Budgetary Control Director

Important FAQs about investing in BLRX Stock from India :

What is Bioline Rx share price today?

Bioline Rx share price today is $3.79 as on at the close of the market. Bioline Rx share today touched a day high of $3.79 and a low of $3.66.

What is the 52 week high and 52 week low for Bioline Rx share?

Bioline Rx share touched a 52 week high of $26.80 and a 52 week low of $2.30. Bioline Rx stock price today i.e. is closed at $3.79, lower by 85.86% versus the 52 week high.

How to invest in Bioline Rx Stock (BLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bioline Rx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioline Rx Shares that will get you 0.3958 shares as per Bioline Rx share price of $3.79 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioline Rx Stock (BLRX) from India?

Indian investors can start investing in Bioline Rx (BLRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Bioline Rx stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Bioline Rx share’s latest price of $3.79 as on August 30, 2025 at 1:29 am IST, you will get 2.6385 shares of Bioline Rx. Learn more about fractional shares .

What are the returns that Bioline Rx has given to Indian investors in the last 5 years?

Bioline Rx stock has given -94.8% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?